Cigna Corp (CI) 130.06 $CI Cigna's Anthem Merger on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cigna Corp (CI) 130.06 $CI

Cigna's Anthem Merger on Tenterhooks, Growth in the Cards
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 9:27AM CDT
Cigna's (CI) merger with Anthem has drawn criticism from the regulators, the company, however, remains poised for long-term growth.
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), AIZ: 87.71 (+0.18), JRVR: 34.51 (+0.09)

Blog Coverage WellCare Health and Centene Plan to Purchase Aetna's Assets
ACCESSWIRE - Mon Jul 11, 8:17AM CDT
LONDON, UK / ACCESSWIRE / July 11, 2016 / Active Wall St. blog coverage looks at the headline from Health insurers, WellCare Health Plans, Inc. (NYSE: WCG) and Centene Corp. (NYSE: CNC) as they made offers to purchase Medicare Advantage insurance portfolio that Aetna Inc. (NYSE: AET) may have to shed, in seeking clearance for regulatory approval for its proposed $37 billion takeover of Humana Inc. (NYSE: HUM), according to a report by Reuters. Register with us now for your free membership and blog access at:
CI: 130.06 (+1.06), CNC: 72.11 (-0.32), ANTM: 133.04 (+1.16), WCG: 106.85 (+1.48), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Watch for CIGNA to Potentially Pullback After Gaining 1.91% Yesterday
Comtex SmarTrend(R) - Fri Jul 08, 2:13PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $126.40 to a high of $129.42. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $129.28 on volume of 906,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 130.06 (+1.06)

SmarTrend Watching for Potential Pullback in Shares of CIGNA After 1.91% Gain
Comtex SmarTrend(R) - Fri Jul 08, 2:12PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $126.40 to a high of $129.42. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $129.28 on volume of 906,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 130.06 (+1.06)

MetLife Divests U.S Retail Advisory Force to MassMutual
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 5:23PM CDT
MetLife, Inc. (MET) has sold its U.S retail advisory force, Premier Client Group, to Massachusetts Mutual Life Insurance Company (MassMutual) for $165 million as per media release.
CI: 130.06 (+1.06), AIZ: 87.71 (+0.18), MET: 40.36 (-0.40), MTG: 6.27 (+0.01)

Radian Group (RDN) Announces Capital Plan, Fuels Liquidity
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 9:22AM CDT
Radian Group (RDN) announced new capital plan in its efforts to return to investment grade ratings in the future. This plan follows the redemption of $325 million surplus notes by Radian Guaranty.
CI: 130.06 (+1.06), RDN: 11.65 (-0.04), AIZ: 87.71 (+0.18), MTG: 6.27 (+0.01)

Cigna Actively Invests in its Hong Kong Business to Improve the Health and Well-Being of Hong Kong People
JCN Newswire - Thu Jul 07, 6:12AM CDT

CI: 130.06 (+1.06)

AEGON Announces Plan to Repurchase 29.3 Million Shares
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 9:40AM CDT
AEGON N.V. (AEG) announced that its board of directors has approved a 29.3 million share buyback plan to offset the dilutive effect of the 2015 final stock dividend.
CI: 130.06 (+1.06), JRVR: 34.51 (+0.09), MTG: 6.27 (+0.01), AEG: 3.88 (+0.03)

Aetna May Divest Parts of its Business to Acquire Humana
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 9:03AM CDT
Aetna Inc. (AET) is planning to shed some of its Medicare Advantage business in some markets, as per sources.
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Cigna and Hill Physicians Medical Group Collaborate to Improve Health and Lower Costs in Northern California
BusinessWire - Fri Jul 01, 7:00AM CDT
--Value-based model provides health care professionals with greater resources and aligned incentives to drive improved health and affordability
CI: 130.06 (+1.06)

Cigna Releases Third Annual Corporate Responsibility Report
BusinessWire - Thu Jun 30, 6:55AM CDT
--Details 2015 Environmental, Social, Governance (ESG) activities
CI: 130.06 (+1.06)

Aetna-Humana Merger Faces Ire from California Commissioner
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:45AM CDT
The California Insurance Commissioner Dave Jones has raised his voice against another pending mega merger between Aetna Inc. (AET) and Humana Inc. (HUM).
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Health Insurers Suffer on High Costs, Unprofitable Exchanges
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 3:52PM CDT
Health Insurers Suffer on High Costs, Unprofitable Exchanges
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Zacks Industry Outlook Highlights: Cigna, UnitedHealth Group, Aetna, Anthem and Humana
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks Industry Outlook Highlights: Cigna, UnitedHealth Group, Aetna, Anthem and Humana
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

U.S. Health Insurers Offer Safety Amid Volatility
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 4:43PM CDT
U.S. Health Insurers Offer Safety Amid Volatility
CI: 130.06 (+1.06), CNC: 72.11 (-0.32), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), WCG: 106.85 (+1.48), AET: 117.90 (+2.40), MOH: 51.83 (+0.68), HUM: 156.12 (+1.41)

UnitedHealth Maintains Profitability, Exits Public Exchange
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 3:50PM CDT
UnitedHealth (UNH) is incurring losses on the individual exchange business that is conducted via the public exchange and has therefore withdrawn from a number of exchanges.
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Zacks Industry Outlook Highlights: UnitedHealth Group, Aetna, Cigna, Humana and Anthem
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:30AM CDT
Zacks Industry Outlook Highlights: UnitedHealth Group, Aetna, Cigna, Humana and Anthem
CI: 130.06 (+1.06), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Health Insurance Industry Outlook - June 2016
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 3:13PM CDT
Health Insurance Industry Outlook - June 2016
CI: 130.06 (+1.06), CNC: 72.11 (-0.32), ANTM: 133.04 (+1.16), UNH: 140.65 (+0.79), WCG: 106.85 (+1.48), AET: 117.90 (+2.40), HUM: 156.12 (+1.41)

Dow 30 Stock Roundup: Microsoft Acquires LinkedIn, Merck to Buy Afferent Pharmaceuticals
Swarup Gupta - Zacks Investment Research - Fri Jun 17, 10:06AM CDT
The Dow suffered significantly last week, weighed down by concerns about the path of rate hikes and a possible Brexit.
CI: 130.06 (+1.06), LNKD: 189.94 (-0.36), JPM: 62.92 (-0.28), UNH: 140.65 (+0.79), MRK: 59.55 (-0.05), MSFT: 53.66 (+0.45), AET: 117.90 (+2.40), AAPL: 97.18 (-0.24), CSCO: 29.77 (+0.16), BHI: 45.06 (-0.76), HUM: 156.12 (+1.41)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Next Ventures Invests in BranchLab to Enhance Healthcare AI

Updated Category News Views 201

Next Ventures Makes Strategic Investment in BranchLab Next Ventures, a prominent venture capital firm dedicated to fostering advancements in whole-person health, has made an exciting strategic investment in BranchLab, a leader in AI-driven solutions for healthcare marketing. This collaboration aims to shift healthcare towards a proactive and interconnected model that...

Continue Reading
Cytokinetics Highlights Promising Aficamten Data for HCM

Updated Category News Views 204

Cytokinetics, Incorporated (Nasdaq: CYTK) made waves back in 2024 when they released data from their pivotal Phase 3 clinical trial SEQUOIA-HCM, focusing on the investigational drug aficamten. This treatment targets symptomatic obstructive hypertrophic cardiomyopathy (HCM), a condition that can wreck lives with its debilitating symptoms. The big reveal came at the Heart...

Continue Reading
Totalkredit A/S: Comprehensive Insights into Cash Flows

Updated Category News Views 169

Overview of Cash Flows at Totalkredit A/S At Totalkredit A/S, we emphasize transparency and clarity in our financial disclosures. Recently, we have conducted a comprehensive analysis of cash flows, focusing on various loan types including open and closed annuities, index-linked loans, and serial loans. This analysis reflects our commitment to maintaining robust financial...

Continue Reading
Bitcoin Approaches $70,000 Amid Regulatory Optimism

Updated Category News Views 47

Bitcoin's steady climb towards the $70,000 mark back in 2024 was no accident—traders were watching the charts closely as a wave of inflows into exchange-traded funds (ETFs) linked to this digital heavyweight kicked off a bullish sentiment. With Bitcoin hovering around $68,720 during that time, it was clear that the market was feeling jittery, especially given how...

Continue Reading
Corporate Visions Welcomes Dom Maida to Enhance AI Strategy

Updated Category News Views 146

Corporate Visions Welcomes Industry Leader to Board Corporate Visions, a recognized leader in evidence-based revenue growth solutions, has announced the appointment of tech veteran Dom Maida to its Board of Directors. Maida is known for his extensive experience in data, technology, and product development, especially from his tenure at Bloomberg where he served as Chief...

Continue Reading